Status:
COMPLETED
Effectiveness of Reminiscence Therapy Versus Cognitive Stimulation in Older Adults With Cognitive Decline
Lead Sponsor:
Paulo Costa
Collaborating Sponsors:
Junta de Freguesia de Santo António dos Olivais
Centro Sociocultural Polivalente de São Martinho
Conditions:
Cognitive Decline
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Although data suggest that non-pharmacologic therapies such as Reminiscence Therapy (RT) and Cognitive Stimulation (CS) can potentially maintain or reverse this trend, cognitive impairment can be a pr...
Eligibility Criteria
Inclusion
- Ability to give informed consent before study commencement;
- Ability to participate in group activities for a period between 45 to 60 minutes;
- No pronounced impairment of their visual and auditory abilities;
- Mild to moderate cognitive decline, assessed as a score equal to or below 20 points in the Six-Item Cognitive Impairment Test (6-CIT).
Exclusion
- Unstable clinical condition;
- Prescribed with cholinesterase inhibitors and/or antipsychotics during the study period.
Key Trial Info
Start Date :
April 20 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 6 2017
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT05187572
Start Date
April 20 2017
End Date
June 6 2017
Last Update
January 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Health Sciences Research Unit: Nursing
Coimbra, Portugal, 3004-011